Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis
Authors
Keywords
Geldanamycin, Hsp90 inhibitor, Paclitaxel, Ovarian cancer, p38/H2AX axis
Journal
TUMOR BIOLOGY
Volume 37, Issue 11, Pages 14745-14755
Publisher
Springer Nature
Online
2016-09-15
DOI
10.1007/s13277-016-5297-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p38α MAPK is required for arsenic-induced cell transformation
- (2015) Hong-Gyum Kim et al. MOLECULAR CARCINOGENESIS
- Involvement of ROS-p38-H2AX axis in novel curcumin analogues-induced apoptosis in breast cancer cells
- (2015) Yinhui Dong et al. MOLECULAR CARCINOGENESIS
- Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial
- (2014) Edward Partridge et al. OBSTETRICS AND GYNECOLOGY
- Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy
- (2013) Jana Franke et al. NATURAL PRODUCT REPORTS
- Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions
- (2012) David S. Hong et al. CANCER TREATMENT REVIEWS
- Inhibition of autophagy stimulate molecular iodine-induced apoptosis in hormone independent breast tumors
- (2011) Preeti Singh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives
- (2011) Kiran Lassi et al. Future Oncology
- Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
- (2011) J.-H. Cheong et al. MOLECULAR CANCER THERAPEUTICS
- Dodging Drug-Resistant Cancer with Diamonds
- (2011) T. J. Merkel et al. Science Translational Medicine
- Proteasome inhibitors in cancer therapy
- (2011) Lisa J. Crawford et al. Journal of Cell Communication and Signaling
- Modulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via, mitochondrial mediated caspase-dependent mechanism
- (2010) Jayaraj Ravindran et al. APOPTOSIS
- The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation
- (2010) Alexander Plotnikov et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- ROS-mediated p38α MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A2-treated U937 cells
- (2009) Wen-Hsin Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting Hsp90: small-molecule inhibitors and their clinical development
- (2008) Tony Taldone et al. CURRENT OPINION IN PHARMACOLOGY
- Serum starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway
- (2008) Chengrong Lu et al. FEBS LETTERS
- Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells
- (2008) Shu-Jun Chiu et al. TOXICOLOGY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started